» Articles » PMID: 12917636

MDM2-ARF Complex Regulates P53 Sumoylation

Overview
Journal Oncogene
Date 2003 Aug 15
PMID 12917636
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation. Ubiquitination of p53 is regulated by ARF, which binds to MDM2 and inhibits its E3 ligase function. P53 is also subjected to modification by conjugation of SUMO-1. We found that a p53 mutant deficient for MDM2 binding (p53(14Q19S)) is poorly sumoylated in vivo compared to wild-type p53. Overexpression of MDM2 increases the level of p53 sumoylation, which is further stimulated by expression of ARF. Stimulation of p53 sumoylation requires a highly conserved region (102-116) encoded by exon 2 of ARF and correlates with the ability of ARF to target p53 to the nucleolus. An MDM2 deletion mutant (MDM2(Delta222-437)) with activated cryptic nucleolar localization signal also targets p53 to the nucleolus and efficiently promotes p53 sumoylation in the absence of ARF. Direct targeting of p53 to the nucleolus enhances its sumoylation in an MDM2- and ARF-dependent fashion. These results show that p53 sumoylation is regulated by MDM2- and ARF-mediated nucleolar targeting.

Citing Articles

Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.

Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R Biology (Basel). 2023; 12(12).

PMID: 38132337 PMC: 10740672. DOI: 10.3390/biology12121511.


The SUMOylation and ubiquitination crosstalk in cancer.

Li K, Xia Y, He J, Wang J, Li J, Ye M J Cancer Res Clin Oncol. 2023; 149(17):16123-16146.

PMID: 37640846 DOI: 10.1007/s00432-023-05310-z.


New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4.

Araujo-Abad S, Rizzuti B, Villamarin-Ortiz A, Pantoja-Uceda D, Moreno-Gonzalez C, Abian O Protein Sci. 2023; 32(8):e4723.

PMID: 37409874 PMC: 10364586. DOI: 10.1002/pro.4723.


SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone.

Gomarasca M, Lombardi G, Maroni P Front Cell Dev Biol. 2022; 10:889002.

PMID: 35465332 PMC: 9020829. DOI: 10.3389/fcell.2022.889002.


The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.

Shi X, Du Y, Li S, Wu H Int J Mol Sci. 2022; 23(7).

PMID: 35408996 PMC: 8998487. DOI: 10.3390/ijms23073639.